ConductScience.org, home

Paper40684152

Tetrandrine slows disease progression on high-resolution computed tomography and lung function decline in artificial stone-associated silicosis: a retrospective cohort study.

Zhou S and 5 others. BMC Pulm Med, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Tetrandrine slows disease progression on high-resolution computed tomography and lung function decline in artificial stone-associated silicosis: a retrospective cohort study. Papers, record 40684152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40684152

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tetrandrine slows disease progression on high-resolution computed tomography and lung function decline in artificial stone-associated silicosis: a retrospective cohort study.
PubMed
Journal
BMC Pulm Med
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-07-22
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhou SShaowei
2Shi JJin
3Chen ZZidan
4Bian LLuqin
5Huang LLimin
6Mao LLing

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SilicosisMajor topic
BenzylisoquinolinesMajor topic
LungMajor topic
Humans
Retrospective Studies
Male
Disease Progression
Middle Aged
Female
Tomography, X-Ray Computed
Respiratory Function Tests
Aged
Adult
China

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NHC202308Key Laboratory of Pneumoconiosis of the National Health CommissionPubMed

Source PubMed

Download CSV of grants

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137258484Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease.Front Biosci (Landmark Ed)2023https://conductscience.org/library/papers/37258484PubMed
232563682Artificial Stone Silicosis: Rapid Progression Following Exposure Cessation.Chest2020https://conductscience.org/library/papers/32563682PubMed
322534002Silicosis.Lancet2012https://conductscience.org/library/papers/22534002PubMed
434070293Association between Crystalline Silica Dust Exposure and Silicosis Development in Artificial Stone Workers.Int J Environ Res Public Health2021https://conductscience.org/library/papers/34070293PubMed
528882991Artificial stone-associated silicosis: a rapidly emerging occupational lung disease.Occup Environ Med2018https://conductscience.org/library/papers/28882991PubMed
626899361Tetrandrine--A molecule of wide bioactivity.Phytochemistry2016https://conductscience.org/library/papers/26899361PubMed
738265677Tetrandrine Alleviates Silica-induced Pulmonary Fibrosis Through PI3K/AKT Pathway: Network Pharmacology Investigation and Experimental Validation.Inflammation2024https://conductscience.org/library/papers/38265677PubMed
830781462Artificial Stone Associated Silicosis: A Systematic Review.Int J Environ Res Public Health2019https://conductscience.org/library/papers/30781462PubMed
938522742Evaluating silicosis risk: Assessing dust constitution and influence of water as a primary prevention measure in cutting and polishing of silica agglomerates, granite and marble.Environ Res2024https://conductscience.org/library/papers/38522742PubMed
106628134[Preliminary study of the mechanism of silicosis therapy by tetrandrine].Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi1983https://conductscience.org/library/papers/6628134PubMed
1127730180Artificial stone dust-induced functional and inflammatory abnormalities in exposed workers monitored quantitatively by biometrics.ERJ Open Res2016https://conductscience.org/library/papers/27730180PubMed
1234417574Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages.Acta Pharmacol Sin2022https://conductscience.org/library/papers/34417574PubMed
1335445039Risk Factors of Silicosis Progression: A Retrospective Cohort Study in China.Front Med (Lausanne)2022https://conductscience.org/library/papers/35445039PubMed
147172937[Autopsy and histochemical analysis: report of a case of silicosis treated with tetrandrine].Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi1982https://conductscience.org/library/papers/7172937PubMed
1532157793Silicosis in artificial stone workers: Spectrum of radiological high-resolution CT chest findings.J Med Imaging Radiat Oncol2020https://conductscience.org/library/papers/32157793PubMed
1639944632Silicosis: from pathogenesis to therapeutics.Front Pharmacol2025https://conductscience.org/library/papers/39944632PubMed
1737851380Toward targeted treatments for silicosis.Curr Opin Pulm Med2024https://conductscience.org/library/papers/37851380PubMed
1816418244Pneumoconiosis: comparison of imaging and pathologic findings.Radiographics2006https://conductscience.org/library/papers/16418244PubMed
1931828940Artificial stone-associated silicosis in China: A prospective comparison with natural stone-associated silicosis.Respirology2020https://conductscience.org/library/papers/31828940PubMed
2036873890Clinical efficacy of tetrandrine in artificial stone-associated silicosis: A retrospective cohort study.Front Med (Lausanne)2023https://conductscience.org/library/papers/36873890PubMed

See all 26 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn Papers
41566645Macrophage-Derived Ferritin Exacerbates Silica-Induced Pulmonary Fibrosis via PIK3R2-Mediated Fibroblast Differentiation.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41566645

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40684152

GET https://conductscience.org/api/papers/v1/40684152/references?page=2